Breast Imaging Industry Veteran Julian Marshall Joins Volpara Solutions as Chief Marketing Officer
WELLINGTON, New Zealand (PRWEB) March 01, 2016 -- Volpara Solutions, the leading provider of volumetric breast density and quantitative breast imaging tools, announced that imaging industry veteran Julian Marshall has joined the company as Chief Marketing Officer.
“With substantial expertise in image analysis and breast imaging workflow, Julian will immediately bolster Volpara’s goal of utilizing digital health solutions and data analytics to ensure women receive the best breast care available. His combined expertise in engineering and global product management is unique and we expect this to help drive the continued growth and adoption of our suite of quantitative imaging tools,” said Ralph Highnam, Ph.D., CEO of Volpara Solutions.
Marshall is a seasoned executive with more than 30 years of engineering and product management experience. He has spent the past 22 years at leading breast imaging technology companies, R2 Technology and Hologic, Inc, holding increasingly senior positions in engineering management and global product management. Most recently, Marshall was Director, Global Strategic Innovation at Hologic, where he was responsible for planning of future product roadmaps.
Marshall holds many patents in the areas of computer-aided detection, user interfaces and workflow, with a focus in breast imaging. Additionally, he has served as a contributing author with DICOM Working Groups 8 and 15 and the IHE Technical Committee subgroup on Mammography. Marshall holds a Bachelor of Science degree in Electrical and Computer Engineering from the University of California, Santa Barbara and Master’s Degree in Mechanical Engineering from Santa Clara University.
“I’m excited to join Volpara Solutions because the company has demonstrated an ability to deliver on a vision of personalized breast health, with which I wholeheartedly agree. With a wealth of expertise in breast image analysis, Volpara is paving the way to improving the overall quality of breast imaging procedures and I am proud to support the team’s efforts to ensure that every woman receives the best mammogram she can possibly get," said Marshall.
Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis data and to determine which women would benefit from additional screening. Highly correlated to breast MR assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the Fourth and Fifth Editions of the Breast Imaging-Reporting and Data System (BI-RADS) Atlas from the American College of Radiology (ACR). VolparaDensity is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.
About Volpara Solutions
Founded with the goal of helping radiologists give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Volpara Health Technologies Limited of New Zealand (formerly Matakina Technology). Cleared by the FDA, HealthCanada, the TGA, and CE-marked, VolparaDensity provides an objective volumetric measure of breast density from both digital mammography and tomosynthesis data. VolparaDensity is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient-specific x-ray dose, breast compression, breast positioning and other factors designed to provide critical insight for breast imaging workflow. For more information, visit http://www.volparasolutions.com
# # #
Chris K Joseph, Volpara Solutions, http://www.volparasolutions.com, +1 (510) 435-4031, [email protected]
Share this article